Filter
829
Filtered Results: 829
Text search:
European
Monitoring
Centre
for
Drugs
and
Drug
Addiction
Featured
Recommendations
73
New Publications
163
Language
Document type
No document type
498
Studies & Reports
146
Guidelines
106
Manuals
39
Strategic & Response Plan
19
Fact sheets
8
Situation Updates
6
Training Material
4
Resource Platforms
3
Countries / Regions
Western and Central Europe
69
Eastern Europe
31
Global
28
Ukraine
24
India
23
Sierra Leone
15
Kenya
15
Africa
14
Nepal
12
Zambia
12
Ghana
11
Russia
11
Nigeria
10
Uganda
10
Eastern Europe and Central Asia
10
Ethiopia
8
Myanmar / Burma
8
Albania
8
Cambodia
7
South Africa
7
Tajikistan
7
Liberia
6
Tanzania
6
Namibia
6
Latin America and the Carribbean
6
Asia
6
Burkina Faso
5
Rwanda
5
Bangladesh
5
Malawi
5
West and Central Africa
5
South–East Asia Region
5
Georgia
5
Senegal
4
Philippines
4
Syria
4
Laos
4
Moldova
4
Congo, Democratic Republic of
3
Zimbabwe
3
Pakistan
3
Jordan
3
Germany
3
Thailand
3
North Macedonia
3
Lesotho
3
East and Southern Africa
3
Morocco
2
South Sudan
2
Lebanon
2
Indonesia
2
Mozambique
2
Eswatini/ Swaziland
2
Botswana
2
Sri Lanka
2
Middle East and North Africa
2
Estonia
2
Kyrgyzstan
2
Vietnam
2
Guinea
1
USA
1
Saudi Arabia
1
Cameroon
1
Iraq
1
Afghanistan
1
Turkey
1
Ireland
1
Sudan
1
Benin
1
Argentina
1
Brazil
1
Serbia
1
Hungary
1
Colombia
1
Greece
1
Mexico
1
Western Pacific Region
1
Fiji
1
Bhutan
1
Poland
1
Armenia
1
Qatar
1
Bulgaria
1
Lithuania
1
Iran
1
Uzbekistan
1
North America
1
Turkmenistan
1
Jamaica
1
Denmark
1
Tunisia
1
Norway
1
Portugal
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
186
Clinical Guidelines
89
Public Health
46
Women & Child Health
24
Key Resources
15
Pharmacy & Technologies
15
Capacity Building
6
Toolboxes
HIV
153
Mental Health
120
TB
103
AMR
68
Pharmacy
38
COVID-19
23
Rapid Response
19
Refugee
15
NCDs
15
Global Health Education
13
Conflict
12
Ebola
10
NTDs
10
Planetary Health
9
Disability
7
Caregiver
6
Polio
4
Specific Hazards
3
Health Financing Toolbox
3
Natural Hazards
1
Zika
1
Reporting system for the general public - This document aims to provide practical guidelines on how to set up national systems for consumers to report adverse reactions to medicines. The purpose is ...
The Strategy aims to protect and improve the well-being
of society and of the individual, to protect and promote
public health, to offer a high l...
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this editi...
In 2018 and early 2019, the WHO Regional Office for Europe’s cultural contexts of health and well-being project worked alongside the University o...
7 April 2022. Aimed at national policymakers, public health and healthcare planners, staff working in reception centres, and healthcare staff caring for...
Guide for coordinators and data collectors - The WHO Operational Package for Assessing, Monitoring...
The update of the ESTC was conducted as a joint endeavour with ERS, consulting experts from international societies and organisations, national TB programmes, civil society and affected communities....
The main objective of this guidance is to provide scientific advice, based on an evidence-based assessment of targeted public health interventions, to facilitate effective screening and vaccination for...
TB remains one of the world’s deadliest infectious diseases, second only to COVID-19, and drug-resistant TB strains are still a major concern. In the fight against TB, urgent investment is critica...
People Who Inject Drugs
In addition, the following individuals of our external expert advisory committee made instrumental contributions to the initial design ... content of the document: Billy Pick, USAID; Daniel Wolfe, Open Society Foundations; Dave Burrows, AIDS Projects Management Group; Fabienne Hariga, United Nations Office on Drugs and Crime; Mauro Guarinieri, the Global Fund to Fight AIDS, Tuberculosis and Malaria; Richard Needle, Office of the U.S. Global AIDS Coordinator; and Sergey Votyagov, EHRN.
Constituting the second part of the World Drug Report 2022, the present booklet contains an overview of the global demand for and supply of ....
The first chapter of the booklet begins with the latest estimates of the number of people who use drugs, the distribution of those users by type of drugs, age and sex, and recent trends in the use of drugs. The chapter also reviews the impact of the coronavirus disease (COVID-19) pandemic on drug use patterns and service provision. Other issues examined in the chapter are the health consequences of drug use, including the number of people in treatment for drug use disorders and the extent of drug injecting and of HIV and hepatitis C among people who inject drugs. The chapter concludes with a review of the extent to which strategies, policies and interventions are in place to respond to the drug use problem.
Scientific advice
Prevention and control of communicable diseases in prison settings.
